National
Korean LGBTQ experts push for peace
Bay Area group praises developments from U.S.-North Korea summit

Members of HOBAK expressed hope for peace on the Korean peninsula. (Photo courtesy of Ryan Sin Photography)
A brief statement signed June 12 by President Donald Trump and North Korean leader Kim Jong Un concluded a historic summit in Singapore. The agreement was short on details but fodder for explosive speculation.
Trump committed the U.S. to vague “security guarantees” in exchange for a “firm and unwavering commitment to complete denuclearization of the Korean peninsula” with no specific language about verification or a timeline.
Trump also called off “war games,” otherwise known as joint U.S. military exercises with South Korea that has heretofore provided an umbrella of protection for the region. The announcement surprised both South Korea President Moon Jae-in and the Pentagon.
“Our military exercises are defensive in nature,” Frank Jannuzi, CEO of the Maureen and Mike Mansfield Foundation and former deputy executive director of Amnesty International USA, told the Los Angeles Blade. “What’s remarkable to me here is that you’ve got Trump unilaterally suspending those exercises and getting nothing for it. It’s not like the North had made a reciprocal pledge to both suspend production of fissile material [that which is capable of sustaining a nuclear fission reaction] and to suspend their large-scale military exercises.”
Trump “is way out of his depth,” “duped” by the violent dictator Kim Jong Un, former CIA Director John Brennan told MSNBC. The statement of principles was something Un had already signed more specifically with South Korea.
Others, however, remain optimistic. Ju-hyun Park, a member of the Communications Committee of Hella Organized Bay Area Koreans (HOBAK), a San Francisco-area collective founded as a home for queer and trans Koreans, told the Los Angeles Blade: “The cancellation of U.S.-ROK [South Korean] military drills and the DPRK’s [North Korea’s] commitment to denuclearization are positive steps towards the realization of peace and reunification on the peninsula. We hope talks continue and result in demilitarization and denuclearization, including of U.S. assets.”
Christine Ahn, co-founder of the Korea policy Institute and founder and international coordinator of Women Cross DMZ—a coalition of women working to end the decades-long stalemated Korean War—told Democracy Now on Tuesday: “This is unprecedented. It’s a new day for the Korean peninsula. The joint statement talks about peace and prosperity and security. It remains the job of civil society, and especially of women’s groups, to be sure we’re included in this peace process.”
Women and LGBTQ Koreans have long been pushing for peace in the region as the best way to secure more freedoms and protections for gender and sexual minorities on the Korean peninsula. Both North and South Korea have been beset by human rights abuses, as well as prejudice from the American-influenced Christian Right against LGBTQ people.
Trump said human rights abuses were discussed “briefly” during the summit, but did not elaborate. Rather, he showed Un a four-minute video produced by WhiteHouse.gov and California-based Destiny Productions about what his country could be. The video comes off as a movie trailer “about a special moment in time when a man is presented one chance that may never be repeated. What will he choose – to show vision and leadership – or not?” Trump, who lavished praise on Un, told reporters that the North Korean leader and his entourage were impressed.
Many experts and activists, including members of HOBAK, watched the summit with both trepidation and excitement since the world leaders are known for being unpredictable. They feel the inclusion of women and LGBTQ communities in peace talks could help to usher in an era of demilitarization and reconciliation and want to offer insights into a better way forward.
HOBAK, a group of 20 grassroots activists, promote gender equality, LGBTQ rights, demilitarization, Korean reunification, and other progressive policies both on the Korean Peninsula and in the U.S. The group believes that American involvement in the ongoing Korean War has only stymied hopes for peace and demilitarization.
“I think we’ve been seeing this again with Donald Trump’s administration, where they have been really fanning the flames of hostility and tension,” Hyejin Shim told the LA Blade. “U.S. occupation has really impacted the politics of South Korea because the U.S. has positioned itself as South Korea’s benefactor and savior. To our understanding, the relationship between the U.S. and the South Korean government—that was a relationship that propped up South Korean dictators for many decades after the Korean War,” started June 25, 1950.
Having women and LGBTQ folks involved in the peacemaking process leads to actual and more lasting peace deals, said Ahn, who has hosted international peace summits in Seoul and Pyongyang. The ongoing state of war is “used by governments on both sides to justify a very repressive national security state. Obviously, on a scale of one to 10, it’s a 10 in North Korea. And in South Korea, it depends on whether it’s a more progressive or liberal administration, versus a neoconservative one.” While she did not minimize North Korea’s record on human rights, Ahn said the treatment of LGBTQ visitors has been worse in South Korea, by comparison.
Ahn has led delegations of Korean-Americans to North Korea, half of whom have been queer. “It’s really extraordinary the percentage of queer Koreans who have been involved in this [peace and de-militarization] movement,” Ahn said. In one instance, a woman asked the government-appointed tour guide “minder” what he imagined Kim Jong-un would say concerning queer people. The “minder” said something to the effect of: “It doesn’t matter what your sexual orientation is, as long as you’re for the revolution and for advancing equality.”
When the woman relayed the story to elderly first-generation Korean-American immigrants in the U.S.—a community traditionally known to be heterosexist and patriarchal—she received a standing ovation. “It just shows there isn’t a monolithic view or experience within North Korea, that there are obviously competing views,” Ahn said. “It’s important to have these honest conversations to bring about change both there and here.”
“We know that nations at war are not friendly to human rights,” she said. “Not to justify it, but why don’t we try a different approach? Why don’t we try engagement? If we can get to peace, a lot of things will improve in the day-to-day existence of people [on the Korean Peninsula].”
Jannuzi agreed that peace and human rights “go hand in hand.” However, he said, “The hostilities don’t account for the lack of a judicial system or trial; the inability to worship; the inability to have access to information; or the restrictions on people to express any criticism of the government. Their policies are draconian. They exercise collective punishment of entire families—children and parents are sent to jail for crimes committed by family members. It’s an authoritarian state that’s keeping a tight grip on its people.”
The United Nations Commission of Inquiry on DPRK (Democratic People’s Republic of Korea—North Korea), Jannuzi noted, found the country is among the world’s more repressive and intolerant societies. “There are maybe 120,000 political prisoners who are in gulags because of their political beliefs. That may include people who are [incarcerated for] their sexual orientation or sexual practices,” but there is a lack of good data on this front.
LGBTQ communities in South Korea, too, face social and political repression. As Pride celebrations unfold in cities and towns across the United States, LGBTQ people in Seoul will risk their safety by taking to the streets in rainbow regalia. Counter-protesters have been known to assault Pride participants, who often wear sunglasses and concealing headgear to guard against accidental or intentional outing because they fear reprisal from their families, employers, friends and communities.
Shim, who is queer, told the LA Blade the South Korean military has been known to root out gay and bisexual men from its ranks by using entrapment techniques. Service members are solicited with gay apps such as Jack’d and Grindr that are often used by men who have sex with men. After they are outed and subsequently discharged from the armed forces, gay and bisexual men face prison sentences because able-bodied men in South Korea between the ages of 18 and 35 must complete two years of compulsory military service. If they don’t complete the full two-year term, they are required to make up the difference in a correctional facility.
Additionally, while consensual same-sex activity is legal among civilians in South Korea, it is punishable by up to two years imprisonment—or institutionalization—if participants are in the military.
Despite the pervasiveness of homophobia in South Korea, HOBAK is hopefully advocating for a comprehensive anti-discrimination law. Pew research found public opinion has shifted toward LGBT acceptance more in South Korea than in any of the other 39 countries surveyed.
Homophobia persists, however, fueled by a Christian conservatism originated in the late 1880s. For instance, South Korean Prime Minister Moon Jae-in has a distinguished record of supporting progressive policies, but answered a campaign question about gay rights by saying he is against homosexuality.
But HOBAK persists, as well. During her most recent trip to Jeju Island, part of South Korea’s Jeju Province, Shim attended Pride celebrations and witnessed the viciousness of counter-protesters wielding signs akin to those brandished by members of the Westboro Baptist Church. “So much of South Korean politics is very interrelated and interconnected,” Shim said. “So there are LGBT folks doing labor stuff—queer people are everywhere, so of course they’re involved in everything.”
Ahn is pleased with the summit. Nuclear weapons would instantly kill 300,000 people on the Korean Peninsula and now Trump no longer has the option to launch a first strike. Ahn believes Women Cross DMZ “planted a seed” in Trump’s mind through a letter they sent him saying he had unique opportunity to do what no American president has successfully done before: bring an end to the longest U.S. conflict.
Jannuzi said that peace would open the door to further negotiations, including those focused on human rights. “I don’t think there’s anything about the North Korean human rights situation that would be improved through coercion,” he said. “Pressure in the form of military pressure or economic sanctions is not the way to convince them to improve their human rights record.”
Jannuzi would like to see a human rights working group that would address human rights and human security issues, including in freedom of expression and religion, as well as protections for LGBTQ people. “Making peace with North Korea,” he said, “is the best way to gain access and leverage to begin to improve human rights in North Korea.”
Jannuzi however, cautioned that this most recent pledge by North Korea to denuclearize is “more vague, weaker, and less specific than almost all of the previous commitments that have been made,” while also extolling the importance of the Summit. “We’ve accomplished very little so far, but we’ve started a process,” he said.
Ahn is focused on peace: “This could be so good for peace in Korea, peace in northeast Asia, for the abolishment of nuclear weapons and for world peace. And we should not be trying to derail it because of our disdain for Trump but see it in the broader picture of what this means for the possibility of a future of world peace.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
-
District of Columbia3 days agoReasons to be optimistic about 2026
-
Commentary5 days agoAmerica is going in the wrong direction for intersex children
-
Movies3 days agoLong-awaited ‘Pillion’ surpasses the sexy buzz
-
Commentary4 days agoProtecting the trans community is not optional for elected allies and candidates
